Concepedia

Ellen Snyder

ES

Statistics

Publications

37

Citations

4.1K

H-Index

26

Active since

1970

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Henry Ford Hospital

St. Luke's Hospital

Duke University

Memorial Sloan Kettering Cancer Center

Ellen Snyder is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Publications per year

1970–2024

37

Publications

37

Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure

Philippe Armand, Margaret A. Shipp, Vincent Ribrag et al. · Journal of Clinical Oncology · 2016 · 672 citations

Medicine, Hematology, Oncology +17

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

David Michelson, Ellen Snyder, Erin M. Paradis et al. · The Lancet Neurology · 2014 · 509 citations

Medicine, Pharmacology, Pharmacotherapy +12

A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression

Ellen Snyder, Bing Cai, Carla DeMuro et al. · Journal of Clinical Sleep Medicine · 2018 · 455 citations · Full text

Medicine, Psychiatry, Behavioral Health +16

Orexin receptor antagonism for treatment of insomnia

W. Joseph Herring, Ellen Snyder, Kerry Budd et al. · Neurology · 2012 · 319 citations

Medicine, Pharmacology, Pharmacotherapy +17

A Cohort Study of Transcutaneous Oxygen Tension and the Incidence and Severity of Retinopathy of Prematurity

John T. Flynn, Eduardo Bancalari, Ellen Snyder et al. · New England Journal of Medicine · 1992 · 318 citations

Medicine, Ophthalmology, Pediatrics +14

1–5 of 37